323
Participants
Start Date
March 14, 2022
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
DFD-29
DFD-29 (40 mg) extended release capsules
Doxycycline
Doxycycline 40 mg capsules
Placebo
Placebo capsules
Clinical Trial Site 24, New York
Clinical Trial Site 01, Sugarloaf
Clinical Trial Site 17, High Point
Clinical Trial Site 04, Wilmington
Clinical Trial Site 08, Coral Gables
Clinical Trial Site 22, Coral Gables
Clinical Trial Site 11, Clearwater
Clinical Trial Site 23, Nashville
Clinical Trial Site 06, Beachwood
Clinical Trial Site 02, Indianapolis
Clinical Trial Site 28, Warren
Clinical Trial Site 18, Ann Arbor
Clinical Trial Site 21, New Brighton
Clinical Trial Site 27, Overland Park
Clinical Trial Site 05, Rogers
Clinical Trial Site 07, Plano
Clinical Trial Site 13, Houston
Clinical Trial Site 20, College Station
Clinical Trial Site 26, San Antonio
Clinical Trial Site 12, San Antonio
Clinical Trial Site 15, Las Vegas
Clinical Trial Site 10, Cerritos
Clinical Trial Site 25, San Diego
Clinical Trial Site 29, San Diego
Clinical Trial Site 03, Fremont
Clinical Trial Site 09, Brighton
Clinical Trial Site 19, East Greenwich
Lead Sponsor
Collaborators (1)
Dr. Reddy's Laboratories Limited
INDUSTRY
Journey Medical Corporation
INDUSTRY